Category: New products
-
Human Organoids Show Drug Activity in Lab Animals
A study shows implanted lab-grown pieces of human 3-D kidney tissue can demonstrate chemical activity of drugs in preclinical tests with lab rats.
-
Precision Microbial Resistance Joint Venture Formed
Biotech, pharma, and diagnostics companies are forming a new business to design precision diagnostics and treatments for drug-resistant microbes.
-
CEPI Funds New Broad Coronavirus Vaccine
An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells.
-
Smell Detection Tech Company Raises $4M in Seed Funds
A start-up biotechnology company creating a system that translates an animal’s sense of smell into electronic signals is raising $4 million in seed equity funds.
-
Cancer Nutrition Therapy Biotech Raises $47M in Early Funds
A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round.
-
Preclinical 3-D Printed Breast Tissue Implant Study Begins
A study is underway testing 3-D printed regenerative breast tissue models, derived from genetically engineered plant cells, implanted in pigs.
-
AI Image Analysis Shown to Predict Embryo Health
An algorithm designed to analyze microscopic images is shown to largely predict the genetic integrity of embryos from in-vitro fertilization.
-
Trial Underway of Nasal Spray Flu Vaccine
A clinical trial has begun testing an influenza vaccine given as a nasal spray with a conventional syringe-delivered vaccine among older U.S. adults.
-
Biotech in $1.5B Gene-Editing Tech License Deal
A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease.
-
Gene Therapy Start-Up Gains $38M in Early Funds
A new company developing genetic treatments with a high-capacity engineered virus to deliver its therapeutic payloads is raising $38 million in venture funds.